Introduction
Intended patient population/medical conditions
The intended patient population using the Astral devices are patients requiring mechanical ventilation.
Mechanical ventilation is indicated when a patient cannot achieve an appropriate level of ventilation to
maintain adequate gas exchange and acid-base balance. It can be delivered in the acute or chronic
environment, and may be delivered invasively or non-invasively to patients who may be non-dependent
or dependent on ventilation.
Patient populations who require acute mechanical ventilation may include:
•
Acute respiratory failure
•
Exacerbation of chronic respiratory conditions
•
Coma
•
Neuromuscular disease
Patient populations who require chronic mechanical ventilation may include:
•
Chronic respiratory failure
•
Patients recovering from acute illnesses and acute respiratory failure who do not respond to repeated
attempts at weaning from a ventilator.
•
Patients with chronic disorders who only require mechanical ventilation for a portion of the day but
can maintain spontaneous ventilation on their own for several hours each day.
•
Patients requiring continuous ventilator support to survive.
Contraindications
The Astral device is contraindicated in patients with the following pre-existing conditions:
•
pneumothorax or pneumomediastinum
•
pathologically low blood pressure, particularly if associated with intravascular volume depletion
•
cerebrospinal fluid leak, recent cranial surgery or trauma
•
severe bullous lung disease
•
dehydration.
WARNING
AutoEPAP is contraindicated when using an invasive interface.
Adverse effects
Report unusual chest pain, severe headache or increased breathlessness to your physician. The following
side effects may arise during use of the device:
•
drying of the nose, mouth or throat
•
nosebleed
•
bloating
•
ear or sinus discomfort
•
eye irritations
•
skin rashes.
2